Cardinal Health Raises Fiscal 2027 Growth Targets for Two Segments

Cardinal Health lifted its fiscal 2027 earnings outlook after first-quarter non-GAAP diluted earnings per share climbed 28% to $3.26, with profit growth in its Pharmaceutical and Specialty Solutions business. Revenue for the three months ended Sept. 30 reached $67.513 billion, a 5% increase from $64.009 billion a year earlier. Net earnings attributable to Cardinal Health were $554 million, up 23%, while diluted EPS rose 27% to $2.38. Non-GAAP operating earnings grew 17% to $1 billion. Cardinal distributes pharmaceutical and specialty products and manufactures and distributes medical and laboratory products.

Source: TokenPost